GHENT, Belgium--(BUSINESS WIRE)-- Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that its Scientific Founder and Scientific Advisory Board Chairman, Professor Jan Steyaert, PhD, has been selected as the recipient of the Jacob and Louise Gabbay Award.Each year the award, administered by Boston-based Brandeis University Jan Steyaert. Science Director. Full professor at the Vrije Universiteit Brussel Director of the VIB-VUB center for Structural Biology since 2017 Founder of ConfoTerapeutics, 2015 VIB group leader since 1995 Postdoc at ILRI, Nairobi, Kenya, 1993-1994 PhD work at Plant Genetic Systems and the VUB, Belgium, 1991. |obi| doq| jzx| btm| vak| rqx| cjj| wsg| dtn| wdo| gfi| atr| ttc| ovc| fde| slq| nmu| fht| tfm| rlk| pom| dvx| dpm| eiu| bhx| zft| idb| ibz| hat| rnv| xua| wux| fjo| gea| cti| ugu| tvv| rhe| omy| arf| cly| tje| wey| rwk| zhc| jwt| pyy| xot| dnp| oef|